Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2016-01-25 Major Shareholding Noti…
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification
2016-01-25 English
BALCHEM CORPORATION 8-K 12-15-2015
Notice of Dividend Amount Classification · 95% confidence The document is a Form 8-K, which is a current report filed with the SEC to announce specific events. The text indicates that the company issued a press release announcing a dividend declared by the Board of Directors. The document itself is short (2412 characters) and primarily references the press release as an exhibit. There are no detailed financial statements or comprehensive reports included. The main content is an announcement of a dividend declaration, which fits the category of Notice of Dividend Amount (DIV).
2015-12-18 English
FORM 4
Director's Dealing
2015-12-03 English
FORM 4
Director's Dealing
2015-11-13 English
BALCHEM CORPORATION 10-Q 9-30-2015
Interim / Quarterly Report Q3 2015
2015-11-04 English
BALCHEM CORPORATION 8-K 11-3-2015
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 3, 2015, reporting earnings for the third quarter ended September 30, 2015. It specifically mentions that the full text of the press release announcing the financial results is attached as Exhibit 99.1. The document itself is short (2743 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights, not a full interim report or annual report. Therefore, the appropriate classification is ER with high confidence.
2015-11-03 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.